Where does Jørgen Søberg Petersen work?

Jørgen Søberg Petersen is Senior Partner at Novo Holdings.

Where did Jørgen Søberg Petersen go to school?

Jørgen Søberg Petersen studied at Københavns Universitet - University of Copenhagen (M.D., Medicine); Københavns Universitet - University of Copenhagen (Ph.D., Pharmacology); DTU - Technical University of Denmark (Executive M.B.A., Innovation Management).

Jørgen Søberg Petersen

Investor

Senior Partner at Novo Holdings

Utrecht, Utrecht, Netherlands

Find your path to Jørgen

1,041 people in our graph share verified history with Jørgen — schools, employers, funds. One of them is your warm intro.

Mahesha SubramaniamunlockedJørgen: together at INSEAD (2017–2018)

×3Jørgen: together at Northwestern University - Kellogg School of Management

Jørgen: together at DTU - Technical University of Denmark

×2Jørgen: together at INSEAD

About

Jørgen Søberg Petersen is a Senior Partner at Novo Holdings, where he has worked since 2017 on the venture capital team focused on building and scaling biotech companies. Trained as a physician-scientist in Denmark and the United States, he previously held R&D and leadership roles at Merck and Novo Nordisk and co-founded Zealand Pharma (NASDAQ: ZEAL.CO), where he served as Chief Scientific Officer. He has been a founding executive or investor in more than a dozen biotech companies, several of which have been taken public or sold.

Contact· self-published, not guessed

j•••@novo.dkreveal

Experience

Novo HoldingsSenior Partnercurrent2024 — presentCopenhagen, Capital Region of Denmark, Denmark
Novo HoldingsPartner2019 — 2024Copenhagen Metropolitan Area
Novo HoldingsVenture Partner2017 — 2019Copenhagen Area, Denmark
AnaCardioNon Executive Director, Board of Directorscurrent2025 — presentStockholm, Stockholm County, Sweden
Antag TherapeuticsNon-Executive Director, Board of Directorscurrent2024 — presentCopenhagen Metropolitan Area
Breye Therapeutics ApSNon-Executive Director, Board of Directorscurrent2022 — presentCopenhagen, Capital Region of Denmark, Denmark
Acesion PharmaChairman of the Board of Directorscurrent2020 — presentCopenhagen Municipality, Capital Region of Denmark, Denmark
HemabNon-Executive Director, Board of Directors2020 — 2026Copenhagen Metropolitan Area
Engimmune TherapeuticsNon-Executive Director, Board of Directors2022 — 2025Basel, Switzerland
Tribune TherapeuticsNon-Executive Director, Board of Directors2021 — 2023Oslo, Norway
Amolyt PharmaNon-Executive Director, Board of Directors2019 — 2020Lyon, France and Boston, MA, USA
VectivBio AGNon-Executive Director, Board of Directors2019 — 2020Basel, Switzerland and New York City, USA
TherachonNon-Executive Director, Board of Directors2018 — 2019Basel, Switzerland
BLUE Healthcare InvestmentsChairman and Owner2015 — 2017Copenhagen, Capital Region of Denmark, Denmark
Imcheck TherapeuticsPresident and Executive Chairman2015 — 2016Greater Marseille Metropolitan Area
Novo Nordisk A/SCorporate Vice President2013 — 2015Målev, Denmark and Seattle, USA
Merck GroupSenior Vice President, Research and Early Clinical Development2012 — 2013Geneva (Switzerland), Boston (US), Darmstadt (Germany), Tel Aviv (Israel)
Merck GroupSenior Vice President, Research2008 — 2011Geneva (Switzerland) and Darmstadt (Germany)
Zealand Pharma A/SExecutive Vice President and Chief Scientific Officer1998 — 2008Glostrup, Denmark
University of Copenhagen, DenmarkProfessor of Pharmacology1995 — 2008
H. Lundbeck A/SHead, Department of Safety Pharmacology (General Pharmacology)1997 — 1998Valby, Denmark
Hospitals and Clinics of University of Copenhagen, DenmarkMedical Doctor (Internal Medicine)1993 — 1995
The University of IowaClinical Research Fellow1990 — 1993Department of Internal Medicine, Iowa City, Iowa, USA

Skills & more

CTMS4Management19Strategy33Leadership8IND3Strategic Leadership14Innovation Management11Biotechnology99Drug Discovery99Immunology81Drug Development99Medicine10

+12 more

Clinical DevelopmentLifesciencesClinical TrialsCardiovascular DiseaseDiabetesKidneyPharmacologyEntrepreneurshipClinical PharmacologyClinical ResearchBiomarkersR&D

Languages Danish · English · French · German

From Jørgen's professional profile.

Colleagues at Novo Holdings

Aaron Nelson

Partner at Novo Holdings

Abhijeet Lele

Senior Partner at Novo Holdings

Alan Liu

Principal at Novo Holdings

Aleks Engel

Partner at Novo Holdings

Alex Grooten

Senior Manager, Head of Accounting at Novo Holdings

Álvaro Gallego Jurado

Manager at Novo Holdings

Amalie Stokkeland

Senior Associate at Novo Holdings

Amer Sheikh

Partner at Novo Holdings

Frequently asked questions

Who is Jørgen Søberg Petersen?: Jørgen Søberg Petersen is a Senior Partner at Novo Holdings, where he has worked since 2017 on the venture capital team focused on building and scaling biotech companies. Trained as a physician-scientist in Denmark and the United States, he previously held R&D and leadership roles at Merck and Novo Nordisk and co-founded Zealand Pharma (NASDAQ: ZEAL.CO), where he served as Chief Scientific Officer. He has been a founding executive or investor in more than a dozen biotech companies, several of which have been taken public or sold.
Where does Jørgen Søberg Petersen work?: Jørgen Søberg Petersen is Senior Partner at Novo Holdings.
Where did Jørgen Søberg Petersen go to school?: Jørgen Søberg Petersen studied at Københavns Universitet - University of Copenhagen (M.D., Medicine); Københavns Universitet - University of Copenhagen (Ph.D., Pharmacology); DTU - Technical University of Denmark (Executive M.B.A., Innovation Management).